Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
Xiancai Ma, Fan Zou, Fei Yu, Rong Li, Yaochang Yuan, Yiwen Zhang, Xiantao Zhang, Jieyi Deng, Tao Chen, Zheng Song, Yidan Qiao, Yikang Zhan, Jun Liu, Junsong Zhang, Xu Zhang, Zhilin Peng, Yuzhuang Li, Yingtong Lin, Liting Liang, Guanwen Wang, Yingshi Chen, Qier Chen, Ting Pan, Xin He, Hui Zhang
Topics & Concepts
Immune systemAntibodyVaccinationVirologyCoronavirusNeutralizing antibodyBiologyImmunizationHeptad repeatImmunologyMedicineCoronavirus disease 2019 (COVID-19)Peptide sequenceInternal medicineInfectious disease (medical specialty)BiochemistryDiseaseGeneSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 Impact on Reproduction